Carmila: Launch of a Share Buyback Program for €10 Million
24 Abril 2024 - 11:43AM
Business Wire
Regulatory News:
Carmila (Paris:CARM) has signed a cash share buyback mandate
with an investment service provider for a maximum amount of €10
million.
The purchase period will start on 29 April 2024 and end, at the
latest, on 31 July 2024.
Approximately 70 000 shares repurchased will be used for the
2021 free share plan for senior executives and employees. The
remainder will be held by Carmila with a view to their future
cancellation.
This operation falls within the framework of Carmila’s share
buyback program, as authorized by the General Meeting of
shareholders of 24 April 2024.
INVESTOR AGENDA
24 July 2024 (after market close): First half 2024
results 25 July 2024: First half 2024 results presentation
17 October 2024 (after market close): Financial information
for the third quarter 2024
ABOUT CARMILA
As the third-largest listed owner of commercial property in
Europe, Carmila was founded by Carrefour and large institutional
investors in order to enhance the value of shopping centres
adjoining Carrefour hypermarkets in France, Spain and Italy. At 31
December 2023, its portfolio was valued at €5.9 billion and is made
up of 201 shopping centres, with leading positions in their
catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”). Carmila has been a member of the SBF
120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Regulatory Information” section of Carmila’s Finance
webpage:https://www.carmila.com/en/finance/regulatory-information/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240424016801/en/
INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of Investor
Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS CONTACT Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Carisma Therapeutics (NASDAQ:CARM)
Gráfica de Acción Histórica
De May 2023 a May 2024